Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications

Overview of attention for article published in Angiogenesis, September 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#50 of 536)
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 1 X user

patent: 8 patents

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 101 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

NOVEL SLOW-RELEASE PRODRUGS

Application WO-2022130300-A1

World Intellectual Property Organisation (WIPO)

Recombinant binding proteins and their use

Grant US-11332501-B2

United States of America

METHOD OF TREATING AMD IN PATIENTS REFRACTORY TO ANTI-VEGF THERAPY

Application EP-3646880-A1

European Patent Office

Method of treating AMD in patients refractory to anti-VEGF therapy

Grant US-10568934-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 4 additional patents.